Clinuvel Pharmaceuticals Ltd
(NAS:CUVL)
$
6.95
(0%)
Market Cap: 350.49 Mil
Enterprise Value: 188.32 Mil
PE Ratio: 15.62
PB Ratio: 2.03
GF Score: 84/100 Clinuvel Pharmaceuticals Ltd (CUVL) Transcripts
- 1